Cargando…

Size-Tunable Strategies for a Tumor Targeted Drug Delivery System

[Image: see text] Nanoparticles have been widely used in tumor targeted drug delivery, while the antitumor effects are not always satisfactory due to the limited penetration and retention. As we all know, there is a paradox that nanoparticles with large sizes tend to distribute around tumor blood ve...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Wenqi, Liu, Rui, Zhou, Yang, Gao, Huile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047275/
https://www.ncbi.nlm.nih.gov/pubmed/32123729
http://dx.doi.org/10.1021/acscentsci.9b01139
_version_ 1783502107312128000
author Yu, Wenqi
Liu, Rui
Zhou, Yang
Gao, Huile
author_facet Yu, Wenqi
Liu, Rui
Zhou, Yang
Gao, Huile
author_sort Yu, Wenqi
collection PubMed
description [Image: see text] Nanoparticles have been widely used in tumor targeted drug delivery, while the antitumor effects are not always satisfactory due to the limited penetration and retention. As we all know, there is a paradox that nanoparticles with large sizes tend to distribute around tumor blood vessels rather than penetrate into tumor parenchyma, while smaller sizes can penetrate deeply but with poor tumor retention. In recent days, an intelligent, size-tunable strategy provided a solution to determine the size problem of nanoparticles and exhibited good application prospects. In this review, we summarize series of stimuli-induced aggregation and shrinkage strategies for tumor targeted drug delivery, which can significantly increase the retention and penetration of nanodrugs in tumor sites at the same time, thus promoting treatment efficacy. Internal (enzymes, pH, and redox) and external (light and temperature) stimuli are introduced to change the morphology of the original nanodrugs through protonation, hydrophobization, hydrogen bond, π–π stacking and enzymolysis-resulted click reactions or dissociation, etc. Apart from applications in oncotherapy, size-tunable strategies also have a great prospect in the diagnosis and real time bioimaging fields, which are also introduced in this review. Finally, the potential challenges for application and future directions are thoroughly discussed, providing guidance for further clinical transformation.
format Online
Article
Text
id pubmed-7047275
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-70472752020-03-02 Size-Tunable Strategies for a Tumor Targeted Drug Delivery System Yu, Wenqi Liu, Rui Zhou, Yang Gao, Huile ACS Cent Sci [Image: see text] Nanoparticles have been widely used in tumor targeted drug delivery, while the antitumor effects are not always satisfactory due to the limited penetration and retention. As we all know, there is a paradox that nanoparticles with large sizes tend to distribute around tumor blood vessels rather than penetrate into tumor parenchyma, while smaller sizes can penetrate deeply but with poor tumor retention. In recent days, an intelligent, size-tunable strategy provided a solution to determine the size problem of nanoparticles and exhibited good application prospects. In this review, we summarize series of stimuli-induced aggregation and shrinkage strategies for tumor targeted drug delivery, which can significantly increase the retention and penetration of nanodrugs in tumor sites at the same time, thus promoting treatment efficacy. Internal (enzymes, pH, and redox) and external (light and temperature) stimuli are introduced to change the morphology of the original nanodrugs through protonation, hydrophobization, hydrogen bond, π–π stacking and enzymolysis-resulted click reactions or dissociation, etc. Apart from applications in oncotherapy, size-tunable strategies also have a great prospect in the diagnosis and real time bioimaging fields, which are also introduced in this review. Finally, the potential challenges for application and future directions are thoroughly discussed, providing guidance for further clinical transformation. American Chemical Society 2020-01-21 2020-02-26 /pmc/articles/PMC7047275/ /pubmed/32123729 http://dx.doi.org/10.1021/acscentsci.9b01139 Text en Copyright © 2020 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Yu, Wenqi
Liu, Rui
Zhou, Yang
Gao, Huile
Size-Tunable Strategies for a Tumor Targeted Drug Delivery System
title Size-Tunable Strategies for a Tumor Targeted Drug Delivery System
title_full Size-Tunable Strategies for a Tumor Targeted Drug Delivery System
title_fullStr Size-Tunable Strategies for a Tumor Targeted Drug Delivery System
title_full_unstemmed Size-Tunable Strategies for a Tumor Targeted Drug Delivery System
title_short Size-Tunable Strategies for a Tumor Targeted Drug Delivery System
title_sort size-tunable strategies for a tumor targeted drug delivery system
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047275/
https://www.ncbi.nlm.nih.gov/pubmed/32123729
http://dx.doi.org/10.1021/acscentsci.9b01139
work_keys_str_mv AT yuwenqi sizetunablestrategiesforatumortargeteddrugdeliverysystem
AT liurui sizetunablestrategiesforatumortargeteddrugdeliverysystem
AT zhouyang sizetunablestrategiesforatumortargeteddrugdeliverysystem
AT gaohuile sizetunablestrategiesforatumortargeteddrugdeliverysystem